pharmcore semaglutide Semaglutide - CoreAge Rx
Description
Method: In this single-center, randomized, double-blind, placebo-controlled trial, PD patients received self-administered liraglutide injections once-daily (1.2 or 1.8 mg, as tolerated) or placebo in a 2:1 study design for 52 weeks after titration
This information helps your doctor decide if your treatment needs to be changed
The efficacy of Dasiglucagon has been recently studied
All participants provided written consent prior to initiation of any study-related activities
